glp 1 and parkinson's Are we measuring the wrong primary outcome for GLP-1 drugs for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep GLP-1 Signalling as a Therapeutic

Anecdotal evidence on social media claiming dramatic benefits from peptides should be treated with significant skepticism for several reasons

Yamada Bee Farm Propolis supports the development of nerve tissue, and is neuroprotective

LXR/CD38 activation drives cholesterol-induced macrophage senescence and [PMID: 38636518] Laboratory literature summary: LXR/CD38 activation drives cholesterol-induced macrophage senescence and neurodegeneration via NAD(+) depletion

Deficiency Carnitine deficiency can be primary or secondary

A good candidate for IV therapy is anyone who requires quick and efficient delivery of fluids, medications, or nutrients